Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II

Summary

Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II is a clinical trial^[1].

Key Facts

• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II is in the country of United States^[2].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's instance of is recorded as clinical trial^[3].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's start time is recorded as +2007-08-31T00:00:00Z^[4].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's end time is recorded as +2009-05-31T00:00:00Z^[5].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's sponsor is recorded as Duke University^[6].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's number of participants is recorded as {'unit': '1', 'amount': '+479'}^[7].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's title is recorded as Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II^[8].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's short name is recorded as CON NIC II^[9].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's ClinicalTrials.gov ID is recorded as NCT00734617^[11].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's research intervention is recorded as niacinamide^[13].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's clinical trial phase is recorded as phase III clinical trial^[14].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's research site is recorded as Duke University Medical Center^[15].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's research subject recruitment status is recorded as completed^[16].
• Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II's study type is recorded as interventional study^[17].